IN8bio, Inc. (INAB) Misses Q2 EPS by 2c

IN8bio, Inc. (NASDAQ: INAB) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• Helus Pharma closes $50M share offering at $4.85 per share
• Triller Group acquires SPCX-linked treasury position after reverse split